Technical Analysis for DTIL - Precision BioSciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 7.62 | -1.04% | -0.08 |
DTIL closed down 1.04 percent on Friday, November 15, 2024, on approximately normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | -1.04% | |
| New 52 Week Closing Low | Bearish | -1.04% |
| Alert | Time |
|---|---|
| Down 2 % | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| Down 1% | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| New 52 Week Low | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.4299 |
| 52 Week Low | 7.48 |
| Average Volume | 76,132 |
| 200-Day Moving Average | 10.71 |
| 50-Day Moving Average | 9.00 |
| 20-Day Moving Average | 8.36 |
| 10-Day Moving Average | 8.21 |
| Average True Range | 0.40 |
| RSI (14) | 30.07 |
| ADX | 14.33 |
| +DI | 15.79 |
| -DI | 28.19 |
| Chandelier Exit (Long, 3 ATRs) | 7.99 |
| Chandelier Exit (Short, 3 ATRs) | 8.69 |
| Upper Bollinger Bands | 9.01 |
| Lower Bollinger Band | 7.71 |
| Percent B (%b) | -0.07 |
| BandWidth | 15.61 |
| MACD Line | -0.29 |
| MACD Signal Line | -0.24 |
| MACD Histogram | -0.0484 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.98 | ||||
| Resistance 3 (R3) | 7.98 | 7.85 | 7.92 | ||
| Resistance 2 (R2) | 7.85 | 7.76 | 7.85 | 7.90 | |
| Resistance 1 (R1) | 7.73 | 7.70 | 7.67 | 7.74 | 7.88 |
| Pivot Point | 7.61 | 7.61 | 7.58 | 7.61 | 7.61 |
| Support 1 (S1) | 7.49 | 7.51 | 7.43 | 7.50 | 7.36 |
| Support 2 (S2) | 7.37 | 7.46 | 7.37 | 7.34 | |
| Support 3 (S3) | 7.25 | 7.37 | 7.32 | ||
| Support 4 (S4) | 7.26 |
